{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:26Z","timestamp":1791214046977,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/01.bor.0000434664.37880.ac","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T10:48:48Z","timestamp":1379501328000},"page":"772-777","source":"Crossref","is-referenced-by-count":57,"title":["The diagnostic utility of autoantibodies in adult and juvenile myositis"],"prefix":"10.1097","volume":"25","author":[{"given":"Sarah L.","family":"Tansley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","first-page":"626","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness J Am D","volume":"46","author":"Sontheimer","year":"2002","journal-title":"ermatol"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of antimelanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology"},{"key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease.","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-16-20210128","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification.","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","article-title":"Myositis autoantibodies.","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155140 kDa doublet protein in juvenile dermatomyositis.","volume":"47","author":"Gunawardena","year":"2007","journal-title":"Rheumatology"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa muscle protein in inclusion body myositis.","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS One"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5-nucleotidase 1A in inclusion body myositis.","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"R12-16-20210128","first-page":"211","article-title":"Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms Arthritis Res T","volume":"15","author":"Tansley","year":"2013","journal-title":"her"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-antibodies have clinical significance for patients with dermatomyositis.","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-MDA5-associated dermatomyositis: expanding the clinical spectrum.","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/rheumatology\/kes073","article-title":"Clinical features of anti-TIF1-alpha antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-gamma or anti-Mi-2 autoantibodies.","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (antithreonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2008.10.051","article-title":"FAMUSP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.","volume":"136","author":"Dupont","year":"2009","journal-title":"Cell"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1091\/mbc.e06-08-0747","article-title":"Dynamic regulation of p53 subnuclear localization and senescence by MORC3.","volume":"18","author":"Takahashi","year":"2007","journal-title":"Mol Biol Cell"},{"key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","article-title":"Autoantibodies in polymyositis.","volume":"18","author":"Targoff","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir Med"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.","volume":"73","author":"Benjamin Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"R25-16-20210128","first-page":"993","article-title":"Anti-TIF1 antibodies (antip155) in adult patients with dermatomyositis: comparison of different diagnostic assays.","volume":"71","author":"Labrador-Horrillo","year":"2012","journal-title":"ARD"},{"key":"R26-16-20210128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","article-title":"Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2.","volume":"51","author":"Ishikawa","year":"2012","journal-title":"Rheumatology"},{"key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of antisignal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R29-16-20210128","first-page":"84","article-title":"Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection.","volume":"31","author":"Jeon","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R30-16-20210128","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DMinterstitial lung disease during disease remission.","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"},{"key":"R31-16-20210128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis.","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J Pediatr"},{"key":"R33-16-20210128","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R35-16-20210128","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R37-16-20210128","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"R38-16-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis.","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R39-16-20210128","first-page":"CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.","volume":"8","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.bor.0000434664.37880.ac","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T10:01:43Z","timestamp":1646560903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201311000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000434664.37880.ac","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}